CLINUVEL PHARMACEUTICALS LIMITED (CUVL) Gross margin 2024–2026
CLINUVEL PHARMACEUTICALS LIMITED (CUVL) gross margin by fiscal year — reported gross profit divided by reported revenue.
82.9%FY2026 · since FY2024: 81.5% → 82.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 82.9% | +1.8 pp |
| FY2025 | 81.2% | -0.3 pp |
| FY2024 | 81.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CUVL financial trends
CUVL RevenueCUVL Net incomeCUVL Net marginCUVL Gross profitCUVL Operating incomeCUVL Operating marginCUVL Operating cash flowCUVL Free cash flowCUVL Capital expendituresCUVL Return on equityCUVL Stock buybacksCUVL Dividends paidCUVL Total assetsCUVL Total liabilitiesCUVL Shareholders’ equityCUVL overview →